Effects of SuperUlam on Supporting Concentration and Mood: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Table 6

Effect of treatment on POMS.

POMS

Baseline (mean ± SE)

Hour 1 (mean ± SE)

Hour 2 (mean ± SE)

Hour 3 (mean ± SE)

Hour 4 (mean ± SE)

Hour 5 (mean ± SE)

SuperUlam

Placebo

SuperUlam

Placebo

SuperUlam

Placebo

SuperUlam

Placebo

SuperUlam

Placebo

SuperUlam

Placebo

Tension

0.30±0.15

0.40±0.18

0.25±0.12

0.35±0.15

0.10±0.07^a

0.35±0.15

0.25±0.16

0.70±0.41

0.15±0.11

0.35±0.15

0.25±0.12

0.20±0.16

Depression

0.10±0.10

0.20±0.16

0.25±0.25

0.20±0.12

0.20±0.20

0.10±0.07

0.05±0.05

0.15±0.11

0.00±0.00^b

0.10±0.10

0.00±0.00^a

0.10±0.07

Anger

0.15±0.11

0.05±0.05

0.25±0.18

0.35±0.15

0.25±0.18^b

0.05±0.05

0.00±0.00^b

0.15±0.15

0.00±0.00^b

0.10±0.10

0.00±0.00

0.00±0.00

Vigor

8.60±1.30

8.15±1.20

8.10±1.26

7.00±1.16

8.95±1.42

8.00±1.34

8.95±1.39

7.70±1.27

8.80±1.41

8.55±1.30

8.70±1.42

8.00±1.19

Fatigue

0.85±0.35

1.00±0.31

1.30±0.65

1.00±0.41

1.10±0.67

0.90±0.35

0.50±0.19

0.80±0.44

0.45±0.20

0.75±0.42

0.45±0.20

0.45±0.24

Confusion

2.55±0.39

2.40±0.30

2.30±0.31

2.55±0.34

2.50±0.60

2.40±0.30

2.10±0.31

2.75±0.44

2.25±0.32

2.45±0.36

2.35±0.32

2.25±0.30

Total mood disturbance

−4.65±1.75

−4.10±1.57

−3.75±2.18

−2.55±1.72

−4.80±2.57

−4.20±1.70

−6.05±1.74

−3.15±2.10

−5.95±1.69

−4.80±1.89

−5.65±1.72

−5.00±1.49

aP < 0.01 versus placebo at this time point; bP < 0.05 versus placebo at this time point.